share_log

Wedbush:维持Biogen(BIIB.US)中性评级, 目标价由218.00美元调整至247.00美元。

Zhitong Finance ·  Nov 30, 2022 09:40
Wedbush:维持Biogen(BIIB.US)中性评级, 目标价由218.00美元调整至247.00美元。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment